FDA Early Communication about Recent Findings of The Data Collection on Adverse Events of Anti-HIV Drugs Study

Username:....................

Password:....................

Policy Library
Click here for
20,000 policy &
form templates

Home � Browse All Libraries � Food and Drug Administration � FDA Early Communication about Recent Findings of The Data Collection on Adverse Events of Anti HIV Drugs Study

Subject:

FDA Early Communication about Recent Findings of The Data Collection on Adverse Events of Anti-HIV Drugs Study

Category:

Food and Drug Administration (FDA)

Published:

Fri, 28 Mar 2008 - 08:00 am

The FDA has issued an Early Communication about recent findings of The Data Collection on Adverse Events of Anti-HIV Drugs Study. Data analyses from this study indicate a higher risk of heart attack in patients infected with HIV-1 who were taking Ziagen (abacavir) or Videx (didanosine) as part of their drug therapy. The study is a large observational study of 33,347 HIV-1 infected patients living in North America, Europe and Australia. Patients in this study are being followed to evaluate the...

The full article is available to StayAlert subscribers. Click here for a free trial subscription.

RESOURCES:

Customizable Documents and Tools:

Policies, forms and resources are available to subscribers only. Get free trial subscription.

External Links:

External references are available to subscribers only. Get free trial subscription.

StayAlert! provides immediate online healthcare compliance validation to our healthcare users. When faced with dramatic reductions in healthcare dollars, StayAlert! focuses on those processes that can save the most time and money. By automating labor-intensive activities, StayAlert! almost instantly produces a positive impact on the healthcare user's bottom line. The policies alone included with the StayAlert! notices can save you $65,000 or more in labor costs each year. Organizations will realize dramatic cost savings through elimination of labor intensity, increased productivity with the benefit of ensuring regulatory compliance. StayAlert! is the service-oriented supplier of health care's compliance needs.

Other vendors have components of legislated requirements available online or on CD-ROM. However there is no other product that marries regulatory agency mandates with implementation tools, making the latest compliance information immediately available online. No other product provides an interpretative analysis, followed by a practical application tool, therefore providing users with an immediate solution to compliance problems. StayAlert! includes operational components for healthcare organizations, allowing complete facility compliance with mandated requirements, online.